Vigabatrin is a medication used in the management and treatment of infantile spasms and refractory complex partial seizures. It is in the anti-epileptic class of medications. This activity describes vigabatrin's indications, mechanism of action, and contraindications as a valuable agent in treating infantile spasms and refractory complex partial seizures. In addition, this activity will highlight adverse event profile and other key factors (e.g., dosing, pharmacodynamics, pharmacokinetics, monitoring, and efficacy) pertinent for healthcare team members in the management of patients with infantile spasms refractory complex seizures.

**Objectives:**
- Outline the FDA-approved indications of vigabatrin.
- Explain the mechanism of action and administration of vigabatrin.
- Describe the potential adverse effects of vigabatrin.
- Review the importance of improving care coordination amongst the interprofessional team to improve outcomes in patients receiving vigabatrin.